InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,844.61
(
-1.61%
)
US TECH 100
20,579.60
(
0.28%
)
Dow Jones
41,860.44
(
-1.91%
)
Brent Oil
63.45
(
0.00%
)
Bitcoin
110,882.55
(
1.09%
)
Post# of 44695
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ykootss

Send PM Follow Ignore
Followers 0
Posts 14
Boards Moderated 0
Alias Born 12/08/2014

ykootss

Re: None

Monday, 11/02/2020 3:21:53 AM

Monday, November 02, 2020 3:21:53 AM

Post# of 44695
NeuroRX Submits Request for Emergency Use Authorization for RLF-100 in Treatment of COVID-19 Patients with Respiratory Failure & No Other Recourse

NOV 1, 2020 | COVID-19, CYTOKINE STORM, NEURORX, NEWS, POPULAR POSTS, RLF-100


On trialsite.com
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

Lingerie Fighting Championships Coming to the UK for July 4 & 6 Events • BOTY • May 19, 2025 10:00 AM

VAYK Projects to Report Over $400K Q1 Revenue • VAYK • May 15, 2025 9:00 AM

Veri Medtech (VRHI) Reaches $100 Million Revenue Milestone • VRHI • May 15, 2025 8:00 AM

Cannabix Enters Sales Distribution Agreement with Australian Distributor for BreathLogix Autonomous Alcohol Breathalyzer • BLO • May 14, 2025 8:51 AM

North Bay Resources Announces Resource Estimate of 474,000 ounces at Fran Gold Project, British Columbia • NBRI • May 13, 2025 9:58 AM

UC Asset Filed for Public Offering of 8% Dividend Preferred Units • UCASU • May 12, 2025 9:55 AM

Start posting your company's news
Only $200 per official company press release!